mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
PD-0332991 |
FIMM |
pan-cancer |
AAC |
0.36 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.03 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |